Galit Rosen

1.5k total citations · 1 hit paper
15 papers, 780 citations indexed

About

Galit Rosen is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Galit Rosen has authored 15 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Galit Rosen's work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (6 papers) and Acute Myeloid Leukemia Research (4 papers). Galit Rosen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (6 papers) and Acute Myeloid Leukemia Research (4 papers). Galit Rosen collaborates with scholars based in United States, South Korea and France. Galit Rosen's co-authors include Andrea B. Apolo, Manish R. Patel, Patrick Schöffski, John Ellerton, Junyuan Xiong, Alain Ravaud, Luc Dirix, Jeffrey R. Infante, Ding Wang and Carolyn D. Britten and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Galit Rosen

15 papers receiving 772 citations

Hit Papers

Avelumab in metastatic urothelial carcinoma after platinu... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
    2017 429 citations Manish R. Patel, John Ellerton et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galit Rosen United States 10 481 363 150 141 115 15 780
Nunzio Salfi Italy 15 116 0.2× 338 0.9× 110 0.7× 121 0.9× 198 1.7× 37 793
Jared Klein United States 14 229 0.5× 103 0.3× 66 0.4× 290 2.1× 130 1.1× 32 810
Jos Nauta Netherlands 8 232 0.5× 183 0.5× 36 0.2× 131 0.9× 81 0.7× 16 566
J G Kim South Korea 14 231 0.5× 85 0.2× 64 0.4× 91 0.6× 31 0.3× 17 548
F. Smets Belgium 12 241 0.5× 220 0.6× 67 0.4× 168 1.2× 50 0.4× 22 585
Makito Tanaka Japan 15 166 0.3× 83 0.2× 55 0.4× 89 0.6× 118 1.0× 44 588
Sun Young Cho South Korea 13 146 0.3× 101 0.3× 117 0.8× 141 1.0× 127 1.1× 53 526
Wolfgang Hoeltl Austria 11 168 0.3× 1.1k 2.9× 83 0.6× 129 0.9× 174 1.5× 20 1.2k
Ömer Devecioğlu Türkiye 14 116 0.2× 66 0.2× 66 0.4× 69 0.5× 91 0.8× 59 482
Koh Izumiyama Japan 13 124 0.3× 109 0.3× 74 0.5× 207 1.5× 58 0.5× 55 609

Countries citing papers authored by Galit Rosen

Since Specialization
Citations

This map shows the geographic impact of Galit Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Rosen more than expected).

Fields of papers citing papers by Galit Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galit Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Rosen. The network helps show where Galit Rosen may publish in the future.

Co-authorship network of co-authors of Galit Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Galit Rosen. A scholar is included among the top collaborators of Galit Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galit Rosen. Galit Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
West, Kip A., Sanjay Kumar, Martin Scott, et al.. (2023). BOS-371, a monoclonal antibody against IL1RAP: Characterization in preclinical models of AML.. Journal of Clinical Oncology. 41(16_suppl). 7030–7030. 2 indexed citations
2.
Stein, Eytan M., Ibrahim Aldoss, John F. DiPersio, et al.. (2021). Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101). Blood. 138(Supplement 1). 699–699. 41 indexed citations
3.
Patel, Manish R., James L. Gulley, Keun‐Wook Lee, et al.. (2019). Avelumab treatment in metastatic urothelial carcinoma: Association between early response and durable outcomes in the phase Ib JAVELIN Solid Tumor Study.. Journal of Clinical Oncology. 37(7_suppl). 429–429. 1 indexed citations
4.
Apolo, Andrea B., Manish R. Patel, John Ellerton, et al.. (2019). Avelumab treatment in metastatic urothelial carcinoma: Post-hoc analysis of high-risk populations in the phase Ib JAVELIN Solid Tumor Study.. Journal of Clinical Oncology. 37(7_suppl). 428–428. 1 indexed citations
5.
Apolo, Andrea B., John Ellerton, Jeffrey R. Infante, et al.. (2019). Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.. Journal of Clinical Oncology. 37(7_suppl). 425–425. 6 indexed citations
6.
Patel, Manish R., John Ellerton, Jeffrey R. Infante, et al.. (2017). Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial. The Lancet Oncology. 19(1). 51–64. 429 indexed citations breakdown →
7.
Powles, Thomas, Andrea Necchi, Galit Rosen, Hariharan Subramanian, & Andrea B. Apolo. (2017). Anti–Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development. Clinical Genitourinary Cancer. 16(2). 117–129. 26 indexed citations
8.
Apolo, Andrea B., John Ellerton, Jeffrey R. Infante, et al.. (2017). Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.. Journal of Clinical Oncology. 35(15_suppl). 4528–4528. 29 indexed citations
9.
Patel, Manish R., John Ellerton, Jeffrey R. Infante, et al.. (2017). Avelumab in patients with metastatic urothelial carcinoma: Pooled results from two cohorts of the phase 1b JAVELIN Solid Tumor trial.. Journal of Clinical Oncology. 35(6_suppl). 330–330. 24 indexed citations
10.
Gaillard, Charlotte, Taku A. Tokuyasu, Galit Rosen, et al.. (2015). Transcription and methylation analysis of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Haematologica. 100(8). 1064–75. 14 indexed citations
11.
Simms-Waldrip, Tiffany, et al.. (2015). Invasive fungal infections in pediatric hematopoietic stem cell transplant patients. Infectious Diseases. 47(4). 218–224. 22 indexed citations
12.
Rosen, Galit, et al.. (2013). Metabolic syndrome in pediatric cancer survivors: A mechanistic review. Pediatric Blood & Cancer. 60(12). 1922–1928. 34 indexed citations
13.
Rosen, Galit, Kristen Beebe, & Gabriel Q. Shaibi. (2012). Vitamin D levels differ by cancer diagnosis and decline over time in survivors of childhood cancer. Pediatric Blood & Cancer. 60(6). 949–952. 19 indexed citations
14.
Rosen, Galit & Scott C. Kogan. (2006). Acute Promyelocytic Leukemia Stem Cell Derived from Leukemic Progenitor.. Blood. 108(11). 235–235. 1 indexed citations
15.
Rosen, Galit, et al.. (2005). Invasive Fungal Infections in Pediatric Oncology Patients. Journal of Pediatric Hematology/Oncology. 27(3). 135–140. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nunzio Salfi Breakdown of academic impact, for papers by Jared Klein Breakdown of academic impact, for papers by Jos Nauta Breakdown of academic impact, for papers by J G Kim Breakdown of academic impact, for papers by F. Smets Breakdown of academic impact, for papers by Makito Tanaka Breakdown of academic impact, for papers by Sun Young Cho Breakdown of academic impact, for papers by Wolfgang Hoeltl Breakdown of academic impact, for papers by Ömer Devecioğlu Breakdown of academic impact, for papers by Koh Izumiyama
Rankless by CCL
2026